Click Here to return To Results

 

Tumefactive MS Lesions under Fingolimod Neurol 81:1654-1658, Pilz, G.,et al, 2013 See this aricle in Pubmed Article Abstract Our observations add further evidence for the development of atypical demyelinating lesions in some patients receiving fingolimod. These might be related to a treatment-associated shift in the immunopathology of specifically susceptible individuals.

Related Tags

(click to filter results - removes previous filter) adverse drug reaction atypical complications fingolimod iatrogenic neurologic disorders MRI,abnormal multiple sclerosis multiple sclerosis,tumefactive recurrent treatment of neurologic disorder tumefactive lesion

Click Here to return To Results